Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free prostate-specific antigen (Q33178095)

23 July 2017

title

Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free prostate-specific antigen (English)

1 reference

23 July 2017

0 references

Lechevallier E

1

1 reference

23 July 2017

Echazarian C

2

1 reference

23 July 2017

Ortega JC

3

1 reference

23 July 2017

Daniel L

4

1 reference

23 July 2017

Roux F

5

1 reference

23 July 2017

Thirion X

6

1 reference

23 July 2017

Coulange C

7

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

23 July 2017

1 reference

23 July 2017

volume

53

1 reference

23 July 2017

issue

4

1 reference

23 July 2017

page(s)

731-735

1 reference

Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900607-4

7 January 2021

Clearance of free and total serum PSA after prostatic surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900607-4

7 January 2021

The effect of Digital Rectal Examination, Flexible Cystoscopy and Prostatic Biopsy on Free and Total Prostate Specific Antigen, and the Free-to-Total Prostate Specific Antigen Ratio in Clinical Practice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900607-4

7 January 2021

Effect of digital rectal examination and flexible cystoscopy on free and total prostate-specific antigen, and the percentage of free prostate-specific antigen. Differences between two PSA assays

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900607-4

7 January 2021

Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900607-4

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900607-4

7 January 2021

Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900607-4

7 January 2021

10.1016/S0090-4295(98)00607-4

Identifiers

DOI

1 reference

23 July 2017

1 reference